State Street Corp Mersana Therapeutics, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 2,725,394 shares of MRSN stock, worth $6.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,725,394
Previous 2,682,055 1.62%
Holding current value
$6.05 Million
Previous $5.39 Million 4.45%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.23 - $2.25 $53,306 - $97,512
43,339 Added 1.62%
2,725,394 $5.15 Million
Q2 2024

Aug 14, 2024
SELL
$2.0 - $4.45 $5.63 Million - $12.5 Million
-2,815,388 Reduced 51.21%
2,682,055 $5.39 Million
Q1 2024

May 15, 2024
BUY
$2.16 - $5.94 $6.84 Million - $18.8 Million
3,168,009 Added 136.0%
5,497,443 $24.6 Million
Q4 2023

Feb 14, 2024
BUY
$1.11 - $2.34 $18,528 - $39,059
16,692 Added 0.72%
2,329,434 $5.4 Million
Q3 2023

Nov 14, 2023
SELL
$1.06 - $3.91 $2.75 Million - $10.1 Million
-2,592,407 Reduced 52.85%
2,312,742 $2.94 Million
Q2 2023

Aug 14, 2023
SELL
$3.08 - $9.55 $4.64 Million - $14.4 Million
-1,507,073 Reduced 23.5%
4,905,149 $16.1 Million
Q1 2023

May 15, 2023
BUY
$4.0 - $7.02 $2.22 Million - $3.9 Million
556,161 Added 9.5%
6,412,222 $26.4 Million
Q4 2022

Feb 14, 2023
BUY
$5.65 - $7.86 $10.2 Million - $14.1 Million
1,797,041 Added 44.27%
5,856,061 $34.3 Million
Q3 2022

Nov 15, 2022
BUY
$4.63 - $8.0 $11.3 Million - $19.5 Million
2,438,690 Added 150.51%
4,059,020 $27.4 Million
Q2 2022

Aug 15, 2022
BUY
$2.84 - $5.0 $761,631 - $1.34 Million
268,180 Added 19.83%
1,620,330 $7.49 Million
Q1 2022

May 16, 2022
SELL
$3.74 - $6.63 $10.7 Million - $19 Million
-2,868,407 Reduced 67.96%
1,352,150 $5.4 Million
Q4 2021

Feb 14, 2022
BUY
$5.48 - $9.86 $714,378 - $1.29 Million
130,361 Added 3.19%
4,220,557 $26.3 Million
Q3 2021

Nov 15, 2021
BUY
$8.56 - $14.47 $7.22 Million - $12.2 Million
843,673 Added 25.99%
4,090,196 $38.6 Million
Q2 2021

Aug 16, 2021
SELL
$13.28 - $18.07 $6.63 Million - $9.03 Million
-499,477 Reduced 13.33%
3,246,523 $44.1 Million
Q1 2021

May 17, 2021
BUY
$15.31 - $26.52 $9.05 Million - $15.7 Million
591,116 Added 18.74%
3,746,000 $60.6 Million
Q4 2020

Feb 16, 2021
BUY
$16.84 - $27.59 $3.5 Million - $5.74 Million
207,971 Added 7.06%
3,154,884 $84 Million
Q3 2020

Nov 10, 2020
BUY
$16.2 - $25.7 $22.4 Million - $35.5 Million
1,381,464 Added 88.25%
2,946,913 $54.9 Million
Q2 2020

Aug 14, 2020
BUY
$5.24 - $23.4 $4.57 Million - $20.4 Million
872,122 Added 125.79%
1,565,449 $36.6 Million
Q1 2020

May 11, 2020
BUY
$4.41 - $9.28 $3.06 Million - $6.43 Million
693,327 New
693,327 $4.04 Million

Others Institutions Holding MRSN

# of Institutions
121
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $216M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email